Suppliers / Compounds & building blocks

Dark Blue Therapeutics
Oxford, United Kingdom · darkbluetx.com
Dark Blue Therapeutics develops precision oncology medicines focused on novel cancer dependencies and vulnerabilities. It works with academic partners and internal discovery science to advance small-molecule programs for biomarker-selected patient populations. The company is based in Oxford, United Kingdom.
They take quote requests by email.
What they offer
Target validation
Uses functional genomics and informatics-based approaches to identify and validate cancer targets with high transformative potential.
Hit discovery
Discovers starting points for drug programs against selected cancer targets using proprietary data and structural insights.
Hit validation
Evaluates discovered hits to support progression into lead-generation stages.
Hit-to-lead optimization
Optimizes hits into more developed chemical matter using cutting-edge discovery science and medicinal chemistry.
Lead optimization
Refines lead compounds to improve efficacy and mechanism fit for the selected target.
IND-enabling studies
Advances programs through IND-enabling work for clinical development.
What they work on
- Services
- Small molecule, Antibody
- Sites
- Oxford, United Kingdom
Similar suppliers. 2bind Pharma Services, AAPharmaSyn, Aberjona Laboratories, Acellera
Found in a contract services directory. Listing built from darkbluetx.com. Work here? Claim this listing.